Elderly Patients With Acute Myeloid Leukemia (AML), Maintenance Phase After Complete Remission (CR)
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
Phase II Multicentric Trial Open Label, Multicenter, randomized to evaluate the efficacy of a
Maintenance Therapy in First Complete Remission After Induction for Elderly (≥ 60) Fit
Patients With Poor Prognosis Acute Myeloid Leukemia (AML).
The disease-free survival (DFS) of the patients included in this study will be compared to
the ones of the two previously reported groups of patients treated with the same LIA
induction therapy